Chris A. Rallis, Director at FENNEC PHARMACEUTICALS INC. (FENC), sold 1,758 shares at $7.36 ($13K) on 2023-05-19, disclosed to the SEC on 2023-05-19.
Scheduled sale ($13k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.36 | 833 | $6K | 47.4% |
| 2 | $7.36 | 925 | $7K | 52.6% |
| Total | $7.36 avg | 1,758 | $13K | 100% |
| Filing → |
| FENC | SELL | 2025-07-07 | $10K | — | Filing → |
| FENC | SELL | 2025-04-11 | $7K | — | Filing → |
| FENC | SELL | 2025-02-14 | $8K | — | Filing → |